Annual Retained Earnings
-$2.84 B
-$528.63 M-22.90%
December 31, 2023
Summary
- As of February 12, 2025, APLS annual retained earnings is -$2.84 billion, with the most recent change of -$528.63 million (-22.90%) on December 31, 2023.
- During the last 3 years, APLS annual retained earnings has fallen by -$1.91 billion (-206.31%).
- APLS annual retained earnings is now -20419.13% below its all-time high of -$13.83 million, reached on December 31, 2013.
Performance
APLS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.00 B
-$57.45 M-1.95%
September 30, 2024
Summary
- As of February 12, 2025, APLS quarterly retained earnings is -$3.00 billion, with the most recent change of -$57.45 million (-1.95%) on September 30, 2024.
- Over the past year, APLS quarterly retained earnings has dropped by -$161.53 million (-5.69%).
- APLS quarterly retained earnings is now -12082.69% below its all-time high of -$24.62 million, reached on December 31, 2014.
Performance
APLS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
APLS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -5.7% |
| 3 y3 years | -206.3% | -81.0% |
| 5 y5 years | -925.2% | -81.0% |
APLS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.3% | at low | -81.0% | at low |
| 5 y | 5-year | -388.0% | at low | -415.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Apellis Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$3.00 B(+2.0%) |
| Jun 2024 | - | -$2.94 B(+1.3%) |
| Mar 2024 | - | -$2.90 B(+2.3%) |
| Dec 2023 | -$2.84 B(+22.9%) | -$2.84 B(+3.2%) |
| Sep 2023 | - | -$2.75 B(+5.4%) |
| Jun 2023 | - | -$2.61 B(+4.9%) |
| Mar 2023 | - | -$2.49 B(+7.7%) |
| Dec 2022 | -$2.31 B(+39.4%) | -$2.31 B(+7.7%) |
| Sep 2022 | - | -$2.14 B(+9.8%) |
| Jun 2022 | - | -$1.95 B(+8.7%) |
| Mar 2022 | - | -$1.80 B(+8.4%) |
| Dec 2021 | -$1.66 B(+78.8%) | -$1.66 B(+9.8%) |
| Sep 2021 | - | -$1.51 B(+14.9%) |
| Jun 2021 | - | -$1.31 B(+20.0%) |
| Mar 2021 | - | -$1.09 B(+18.1%) |
| Dec 2020 | -$926.35 M | -$926.35 M(-7.8%) |
| Sep 2020 | - | -$1.00 B(+15.6%) |
| Jun 2020 | - | -$868.91 M(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$750.29 M(+29.0%) |
| Dec 2019 | -$581.47 M(+110.1%) | -$581.47 M(+24.2%) |
| Sep 2019 | - | -$468.25 M(+17.5%) |
| Jun 2019 | - | -$398.43 M(+21.7%) |
| Mar 2019 | - | -$327.34 M(+18.3%) |
| Dec 2018 | -$276.77 M(+85.4%) | -$276.77 M(+15.2%) |
| Sep 2018 | - | -$240.31 M(+17.6%) |
| Jun 2018 | - | -$204.33 M(+19.5%) |
| Mar 2018 | - | -$171.00 M(+14.6%) |
| Dec 2017 | -$149.26 M(+51.9%) | -$149.26 M(+13.9%) |
| Sep 2017 | - | -$131.01 M(+9.7%) |
| Jun 2017 | - | -$119.43 M(+21.6%) |
| Dec 2016 | -$98.26 M(+38.1%) | -$98.26 M(+38.1%) |
| Dec 2015 | -$71.13 M(+189.0%) | -$71.13 M(+13.1%) |
| Sep 2015 | - | -$62.92 M(+98.3%) |
| Jun 2015 | - | -$31.73 M(+28.9%) |
| Dec 2014 | -$24.62 M(+78.0%) | -$24.62 M |
| Dec 2013 | -$13.83 M | - |
FAQ
- What is Apellis Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual retained earnings year-on-year change?
- What is Apellis Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly retained earnings year-on-year change?
What is Apellis Pharmaceuticals annual retained earnings?
The current annual retained earnings of APLS is -$2.84 B
What is the all time high annual retained earnings for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual retained earnings is -$13.83 M
What is Apellis Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, APLS annual retained earnings has changed by -$528.63 M (-22.90%)
What is Apellis Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of APLS is -$3.00 B
What is the all time high quarterly retained earnings for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly retained earnings is -$24.62 M
What is Apellis Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, APLS quarterly retained earnings has changed by -$161.53 M (-5.69%)